Why the study?
Does flecainide safely and effectively restore and maintain sinus rhythm in patients with atrial fibrillation without significant structural heart disease?
Does flecainide safely and effectively restore and maintain sinus rhythm in patients with atrial fibrillation without significant structural heart disease?
Flecainide is a safe and effective first-line treatment for restoring and maintaining sinus rhythm in patients with atrial fibrillation who lack significant structural heart disease.
No takes yet. Share an insight, caveat, or question.
May support flecainide as first-line in eligible AF patients; leaves open prospective confirmation in contemporary cohorts.
Aliot et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: